 |
Recombinant human monoclonal IgG1 antibody against programmed death ligand-1 |
|---|---|
| Trade Name | Bavencio |
| Orphan Indication | Merkel cell cancer |
| EU Market Approval | EU |
| EU Designation Date | 2015-12-14 00:00:00 |
| Sponsor | Merck Serono Europe Limited |
Related Access Program